Detalhe da pesquisa
1.
Ceftazidime-avibactam in the treatment of bacteremia due to carbapenem-resistant gram-negative bacteria in hematological patients: Experience in a single center.
J Infect Chemother
; 30(7): 608-615, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215820
2.
Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae in hematological patients: assessment of risk factors for mortality and treatment options.
Ann Clin Microbiol Antimicrob
; 22(1): 41, 2023 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37202758
3.
Update of clinical application in ceftazidime-avibactam for multidrug-resistant Gram-negative bacteria infections.
Infection
; 50(6): 1409-1423, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35781869
4.
Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa in patients with hematological diseases.
Front Cell Infect Microbiol
; 13: 1156651, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37415825
5.
Venetoclax plus hypomethylating agents versus intensive chemotherapy for hematological relapse of myeloid malignancies after allo-HSCT.
Front Oncol
; 13: 1137175, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37035180
6.
Allogeneic stem cell transplantation can prolong the survival of patients with NUP98-rearranged acute myeloid leukemia.
Bone Marrow Transplant
; 58(10): 1149-1151, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37420010
7.
Pseudomonas aeruginosa bloodstream infection in patients with hematological diseases: Clinical outcomes and prediction model of multidrug-resistant infections.
J Infect
; 86(1): 66-117, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36064048
8.
The enhanced immune response of PCV-2 vaccine using Rehmannia glutinosa polysaccharide liposome as an adjuvant.
Int J Biol Macromol
; 86: 929-36, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26851361